ANI Launches Hydrocortisone Rectal Cream
ANI announced the launch of Hydrocortisone Cream for Rectal Use.
Hydrocortisone Rectal Cream is a topical corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in humans.
Hydrocortisone Rectal Cream is available as a 1% strength in 1oz tubes and as a 2.5% strength in 30g tubes.
For more information call (800) 434-1121 or visit AniPharmaceuticals.com.